Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,442 INR | -0.08% | +1.49% | -6.35% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Weaknesses
- The firm trades with high earnings multiples: 25.47 times its 2024 earnings per share.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.35% | 1.34B | - | ||
-1.75% | 77.87B | C+ | ||
-12.97% | 30.63B | A- | ||
-13.83% | 14.66B | B | ||
-3.81% | 13.83B | B+ | ||
-16.12% | 11.43B | B+ | ||
-16.71% | 7.04B | B | ||
-8.10% | 6.89B | B- | ||
-14.49% | 2.75B | B- | ||
-15.90% | 2.71B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- AKZOINDIA Stock
- AKZOINDIA Stock
- Ratings Akzo Nobel India Limited